Earnings & Company Risk
Sema4 Faces Revenue Concentration Risk as Reproductive Health Exit Looms
ViaNews Editorial Team (Markets)•
#genomics
2 articles
Technology
Illumina Q4 Earnings: Can Genomics Leader Sustain Growth?
ViaNews Editorial Team (Markets)•